Telomerase re-expression in postmorterm CNS Progenitors.
Telomerase re-expression in postmorterm CNS Progenitors.
批准号:
6794018
负责人:
Robert Mark Richardson
金额:
$1.34万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-08-01 至 2004-12-31
关键词:
Parkinson&aposs diseaseapoptosiscell differentiationcell linecell proliferationcell typecentral nervous systemgene expressionhuman tissuelaboratory ratnervous system regenerationneuronspostmortemstem cell transplantationstem cellstelomerasetransfectiontransposon /insertion elementtyrosine 3 monooxygenase
中文摘要
描述(由申请方提供):使用CNS股骨柄的移植策略
细胞提供了巨大的潜力,
帕金森?的疾病和其他神经系统疾病。CNS移植物的能力
如果要提供治疗效果,
大量的PD患者。此外,必须有一个足够的
供体细胞的来源。该提案的目的是插入人类
端粒酶基因转染人死后神经前体细胞
(HPCPs),以提高移植细胞的存活率,
增加所需细胞类型的增殖。HPCP提供了一个简单的
可获得的供体来源,hTERT的异位表达是一种合乎逻辑的手段,
在培养中使这些细胞永生化并降低它们的易感性
移植后的凋亡性死亡。确定异位妊娠的影响
端粒酶在HPCPs中表达对群体增殖、抗凋亡的影响
而分化成所有类型的中枢神经系统细胞是关键的第一步
研究这些方法。评估其生存能力、增殖能力和
hTERT+ HPCPs移植到6-OHDA损伤大鼠模型中的不同命运
帕金森?的疾病,并评估移植功能恢复
接受者将进一步描述这些方法可以在多大程度上
有助于未来神经系统疾病的干细胞治疗。为
治疗帕金森?疾病,未来的步骤可能包括将这些
方法与策略可能诱导多巴胺能的命运之间的一个子集,
这些祖先。
英文摘要
DESCRIPTION (provided by applicant): Transplantation strategies using CNS stem
cells offer tremendous potential for replacing neuronal circuitry lost to
Parkinson?s disease and other neurological disorders. The ability of CNS grafts
to survive after transplant is crucial if therapeutic benefit is to be provided
to a large number of patients with PD. Additionally, there must be an adequate
source of donor cells. The purpose of this proposal is to insert the human
telomerase gene (hTERT) into human postmortem-derived neural progenitor cells
(HPCPs) in order to improve the survival of transplanted cells and ultimately
increase the proliferation of desired cell types. HPCPs provide an easily
accessible donor source, and ectopic expression of hTERT is a logical means by
which to immortalize these cells in culture and decrease their susceptibility
to apoptotic death following transplantation. Determining the effect of ectopic
telomerase expression in HPCPs on population doublings, resistance to apoptosis
and ability to differentiate into all CNS cell types is the crucial first step
in investigating these methods. Assessing the viability, proliferation and
differential fates of hTERT+ HPCPs transplanted to a 6-OHDA lesioned rat model
of Parkinson?s disease, and evaluating functional recovery in transplant
recipients will further characterize the extent to which these approaches may
contribute to future stem cell therapy for neurological disorders. For the
treatment of Parkinson? disease, a future step may include combining these
methods with strategies likely to induce a dopaminergic fate among a subset of
these progenitors.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Ectopic telomerase expression inhibits neuronal differentiation of NT2 neural progenitor cells.
异位端粒酶表达抑制 NT2 神经祖细胞的神经元分化。
DOI:
10.1016/j.neulet.2007.03.079
发表时间:
2007
期刊:
Neuroscience letters
影响因子:
2.5
作者:
[Richardson,RMark, Nguyen,Binh, Holt,ShawnE, Broaddus,WilliamC, Fillmore,HelenL]
通讯作者:
Fillmore,HelenL
DOI:
10.3171/jns.2004.100.4.0659
发表时间:
2004
期刊:
Journal of neurosurgery
影响因子:
4.1
作者:
[Richardson,RMark, Fillmore,HelenL, Holloway,KathrynL, Broaddus,WilliamC]
通讯作者:
Broaddus,WilliamC
Electrographic Seizure Pattern Modulation Biomarkers in Responsive Neurostimulation for Epilepsy
-
批准号:10652094
-
项目类别:
-
资助金额:$83.69万
-
财政年份:2023
-
负责人:Robert Mark Richardson
-
依托单位:
Cortical-Basal Ganglia Speech Networks
-
批准号:10044852
-
项目类别:
-
资助金额:$119.6万
-
财政年份:2020
-
负责人:Robert Mark Richardson
-
依托单位:
Cortical-Basal Ganglia Speech Networks
-
批准号:10265463
-
项目类别:
-
资助金额:$115.25万
-
财政年份:2020
-
负责人:Robert Mark Richardson
-
依托单位:
Cortical-Basal Ganglia Speech Networks
-
批准号:10475681
-
项目类别:
-
资助金额:$117.45万
-
财政年份:2020
-
负责人:Robert Mark Richardson
-
依托单位:
Cortical-Basal Ganglia Speech Networks
-
批准号:10663277
-
项目类别:
-
资助金额:$119.73万
-
财政年份:2020
-
负责人:Robert Mark Richardson
-
依托单位:
CRCNS: Deep Neural Network Approaches for Closed-Loop Deep Brain Stimulation
-
批准号:10021999
-
项目类别:
-
资助金额:$22.87万
-
财政年份:2019
-
负责人:Robert Mark Richardson
-
依托单位:
CRCNS: Deep Neural Network Approaches for Closed-Loop Deep Brain Stimulation
-
批准号:10025184
-
项目类别:
-
资助金额:$22.17万
-
财政年份:2019
-
负责人:Robert Mark Richardson
-
依托单位:
Effect of AADC gene transfer on L-dopa induced dyskinesia in MPTP monkeys
-
批准号:7613935
-
项目类别:
-
资助金额:$5.13万
-
财政年份:2009
-
负责人:Robert Mark Richardson
-
依托单位:
Telomerase re-expression in postmorterm CNS Progenitors.
-
批准号:6643467
-
项目类别:
-
资助金额:$3.41万
-
财政年份:2002
-
负责人:Robert Mark Richardson
-
依托单位:
Telomerase re-expression in postmorterm CNS Progenitors.
-
批准号:6529774
-
项目类别:
-
资助金额:$3.13万
-
财政年份:2002
-
负责人:Robert Mark Richardson
-
依托单位:
Telomerase re-expression in postmorterm CNS Progenitors.
-
批准号:6405341
-
项目类别:
-
资助金额:$2.86万
-
财政年份:2001
-
负责人:Robert Mark Richardson
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: